With 4.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.08 million shares. The 52-week range on MRSN shows that it touched its highest point at $6.28 and its lowest point at $0.49 during that stretch. It currently has a 1-year price target of $4.71. Beta for the stock currently stands at 1.64.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MRSN was down-trending over the past week, with a drop of -9.47%, but this was down by -17.99% over a month. Three-month performance dropped to -76.23% while six-month performance fell -62.58%. The stock lost -86.04% in the past year, while it has lost -63.10% so far this year. A look at the trailing 12-month EPS for MRSN yields -0.61 with Next year EPS estimates of -0.75. For the next quarter, that number is -0.16. This implies an EPS growth rate of 58.81% for this year and -22.48% for next year. EPS is expected to grow by 18.77% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 11.93%.
Float and Shares Shorts:
At present, 122.87 million MRSN shares are outstanding with a float of 85.06 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MRSN since 5 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.54887 being high and -$0.66863 being low. For MRSN, this leads to a yearly average estimate of -$0.60875. Based on analyst estimates, the high estimate for the next quarter is -$0.14 and the low estimate is -$0.2. The average estimate for the next quarter is thus -$0.17.
